Results 131 to 140 of about 2,229,234 (312)

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups

open access: yesBritish Journal of Haematology, EarlyView.
Summary Most patients treated for chronic lymphocytic leukaemia (CLL) fail to achieve measurable residual disease (MRD) negativity. The role of maintenance with the immunomodulatory drug lenalidomide in these patients is unclear. A randomised multicentre phase III trial (ACTRN12610000060044) was conducted in Australia and France to assess the effect of
Thérèse Aurran‐Schleinitz   +45 more
wiley   +1 more source

Description of the Acute Leukemia dataset.

open access: yes, 2015
Abbreviations: B-ALL, B-cell acute lymphoblastic leukemia; MLL, myeloid/lymphoid or mixed-lineage leukemia; pre, precursor; c-ALL, childhood acute lymphoblastic leukemia; T-ALL, T-cell acute lymphoblastic leukemia; ALL, acute lymphoblastic leukemia; AML,
Xiang Zhang (19800)   +4 more
core   +1 more source

Consensus recommendations on diagnosis and management of posterior reversible encephalopathy syndrome in paediatric haematopoietic stem cell transplantation

open access: yesBritish Journal of Haematology, EarlyView.
Summary Posterior reversible encephalopathy syndrome (PRES) is a rare but potentially life‐threatening neurological complication following paediatric allogeneic haematopoietic stem cell transplantation (HSCT). Its heterogeneous presentation and the absence of standardized guidance contribute to variability in diagnosis and management.
Davide Leardini   +25 more
wiley   +1 more source

Avascular necrosis of the femoral head as the first manifestation of acute lymphoblastic leukemia

open access: yes, 2006
PubMedID: 16502568Avascular necrosis of bone is a well-described complication of cancer chemotherapy containing corticosteroids and has been observed in lymphomas and acute lymphoblastic leukemia (ALL). This study reports the case of a young male patient
Öçal F., Gürkan E., Yildiz I.
core   +1 more source

The leukaemia in pregnancy study, a national multicentre retrospective study of pregnancy outcomes in women with concurrent or historic diagnoses of acute leukaemia

open access: yesBritish Journal of Haematology, EarlyView.
Summary The leukaemia in pregnancy study was a multicentre retrospective study of pregnancy outcomes of women with concurrent (CAL) or previous (PAL) acute leukaemia. Cases were identified from eight hospitals. Of 39 screened cases, 12 CAL and 21 PAL cases were described, with one belonging to both groups.
Lukas Pitel   +14 more
wiley   +1 more source

Acute Lymphoblastic Leukemia and Seizures

open access: yes, 1995
The incidence, timing, etiologies, and recurrence rate of seizures among 127 pediatric patients with acute lymphoblastic leukemia (ALL) were determined at the Schneider Children’s Hospital, and the Long Island Jewish Medical Center, New ...
J Gordon Millichap, Millichap, J. Gordon
core   +1 more source

Patient‐specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancy

open access: yesBritish Journal of Haematology, EarlyView.
Standardised DNA based measurable residual disease (MRD) monitoring is possible for acute myeloid leukaemia (AML) and myeloid malignancy patients. Targeted next‐generation sequencing (NGS) and RNA‐seq permit marker development for clinically identified lesions and whole genome sequencing (WGS) permits MRD marker development in patients without ...
Libby Huang   +45 more
wiley   +1 more source

Blinatumomab in acute lymphoblastic leukemia [PDF]

open access: yesExpert Review of Anticancer Therapy, 2016
Thomas, Xavier, Lejeune, Caroline
openaire   +3 more sources

Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis [PDF]

open access: yes, 2008
AML1/RUNX1 is a critical transcription factor in hematopoietic cell differentiation and proliferation. From the _AML1_ gene, at least three isoforms, _AML1a_, _AML1b_ and _AML1c_, are produced through alternative splicing.
Zhen Tian   +8 more
core  

Home - About - Disclaimer - Privacy